84R12960 MEW-F
 
  By: Crownover H.B. No. 2847
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to policies and training regarding the use of epinephrine
  auto-injectors by school districts and open-enrollment charter
  schools; providing immunity.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Chapter 38, Education Code, is amended by adding
  Subchapter E to read as follows:
  SUBCHAPTER E.  MAINTENANCE AND ADMINISTRATION OF EPINEPHRINE
  AUTO-INJECTORS
         Sec. 38.201.  DEFINITIONS.  In this subchapter:
               (1)  "Advisory committee" means the committee
  established under Section 38.202.
               (2)  "Anaphylaxis" means a sudden, severe, and
  potentially life-threatening allergic reaction that occurs when a
  person is exposed to an allergen.
               (3)  "Epinephrine auto-injector" means a disposable
  medical drug delivery device that contains a premeasured single
  dose of epinephrine that is intended to be used to treat
  anaphylaxis.
               (4)  "Physician" means a person who holds a license to
  practice medicine in this state.
         Sec. 38.202.  ADVISORY COMMITTEE:  ESTABLISHMENT AND
  COMPOSITION.  (a)  The commissioner of state health services shall
  establish an advisory committee to examine and review the
  administration of epinephrine auto-injectors to a person
  experiencing an anaphylactic reaction on a campus of a school
  district or an open-enrollment charter school.
         (b)  The advisory committee shall be composed of members
  appointed by the commissioner of state health services. In making
  appointments, the commissioner shall ensure that:
               (1)  a majority of the members are physicians with
  expertise in treating anaphylaxis, including physicians who
  specialize in the fields of pediatrics, allergies, asthma, and
  immunology; and
               (2)  at least one member is a registered nurse employed
  by a school district or open-enrollment charter school as a school
  nurse.
         (c)  A member of the advisory committee serves at the
  pleasure of the commissioner of state health services.
         (d)  A vacancy on the advisory committee is filled by the
  commissioner of state health services in the same manner as other
  appointments to the advisory committee.
         Sec. 38.203.  ADVISORY COMMITTEE: PRESIDING OFFICER.  The
  advisory committee shall elect a presiding officer.
         Sec. 38.204.  ADVISORY COMMITTEE: COMPENSATION AND
  EXPENSES.  Members of the advisory committee serve without
  compensation but are entitled to reimbursement for travel expenses.
         Sec. 38.205.  ADVISORY COMMITTEE:  APPLICABILITY OF OTHER
  LAW.  Chapter 2110, Government Code, does not apply to the advisory
  committee.
         Sec. 38.206.  ADVISORY COMMITTEE:  OPEN MEETINGS.  Meetings
  of the advisory committee are subject to Chapter 551, Government
  Code.
         Sec. 38.207.  ADVISORY COMMITTEE: DUTIES.  The advisory
  committee shall advise the commissioner of state health services
  on:
               (1)  the storage and maintenance of epinephrine
  auto-injectors on school campuses;
               (2)  the training of school personnel in the
  administration of an epinephrine auto-injector; and
               (3)  a plan for one or more school personnel members
  trained in the administration of an epinephrine auto-injector to be
  on each school campus.
         Sec. 38.208.  MAINTENANCE AND ADMINISTRATION OF EPINEPHRINE
  AUTO-INJECTORS.  (a)  Each school district and open-enrollment
  charter school may adopt and implement a policy regarding the
  maintenance, administration, and disposal of epinephrine
  auto-injectors at each campus in the district or school.
         (b)  If a policy is adopted under Subsection (a), the policy:
               (1)  must provide that school personnel who are
  authorized and trained may administer an epinephrine auto-injector
  to a person who is reasonably believed to be experiencing
  anaphylaxis on a school campus; and
               (2)  may provide that school personnel who are
  authorized and trained may administer an epinephrine auto-injector
  to a person who is reasonably believed to be experiencing
  anaphylaxis at an off-campus school event or while in transit to or
  from a school event.
         (c)  The commissioner of state health services, in
  consultation with the commissioner of education, and with advice
  from the advisory committee, shall adopt rules regarding the
  administration of an epinephrine auto-injector at a school campus
  subject to a policy adopted under Subsection (a).  The rules must
  establish:
               (1)  the number of epinephrine auto-injectors
  available at each campus;
               (2)  the process for each school district and
  open-enrollment charter school to check the inventory of
  epinephrine auto-injectors at regular intervals for expiration and
  replacement; and
               (3)  the amount of training required for school
  personnel to administer an epinephrine auto-injector.
         (d)  Each school district and open-enrollment charter school
  that adopts a policy under Subsection (a) must require that each
  campus have one or more school personnel members authorized and
  trained to administer an epinephrine auto-injector present during
  all hours the campus is open.
         (e)  The supply of epinephrine auto-injectors at each campus
  must be stored in a secure location and be easily accessible to
  school personnel authorized and trained to administer an
  epinephrine auto-injector.
         Sec. 38.209.  REPORT ON ADMINISTERING EPINEPHRINE
  AUTO-INJECTOR.  (a)  Not later than the 10th business day after the
  date a school personnel member administers an epinephrine
  auto-injector in accordance with a policy adopted under Section
  38.208(a), the school shall report the information required under
  Subsection (b) to:
               (1)  the school district or the charter holder if the
  school is an open-enrollment charter school;
               (2)  the physician who prescribed the epinephrine
  auto-injector;
               (3)  the commissioner of education; and
               (4)  the commissioner of state health services.
         (b)  The report required under this section must include the
  following information:
               (1)  the age of the person who received the
  administration of the epinephrine auto-injector;
               (2)  whether the person who received the administration
  of the epinephrine auto-injector was a student, a school personnel
  member, or a visitor;
               (3)  the physical location where the epinephrine
  auto-injector was administered;
               (4)  the number of doses of epinephrine auto-injector
  administered;
               (5)  the title of the person who administered the
  epinephrine auto-injector; and
               (6)  any other information required by the commissioner
  of education.
         Sec. 38.210.  TRAINING. (a)  Each school district and
  open-enrollment charter school that adopts a policy under Section
  38.208(a) is responsible for training school personnel in the
  administration of an epinephrine auto-injector.
         (b)  Training required under this section must:
               (1)  include information on:
                     (A)  recognizing the signs and symptoms of
  anaphylaxis;
                     (B)  administering an epinephrine auto-injector;
                     (C)  implementing emergency procedures, if
  necessary, after administering an epinephrine auto-injector; and
                     (D)  properly disposing of used or expired
  epinephrine auto-injectors; and
               (2)  be provided in a formal training session or
  through online education and be completed annually.
         (c)  Each school district and open-enrollment charter school
  shall maintain records on the training required under this section.
         Sec. 38.211.  PRESCRIPTION OF EPINEPHRINE AUTO-INJECTORS.  
  (a)  A physician may prescribe epinephrine auto-injectors in the
  name of a school district or open-enrollment charter school.
         (b)  A physician  who prescribes epinephrine auto-injectors
  under Subsection (a) shall provide the school district or
  open-enrollment charter school with a standing order for the
  administration of an epinephrine auto-injector to a person
  reasonably believed to be experiencing anaphylaxis.
         (c)  The standing order under Subsection (b) is not required
  to be patient-specific, and the epinephrine auto-injector may be
  administered to a person without an established physician-patient
  relationship.
         (d)  Notwithstanding any other provisions of law,
  supervision or delegation by a physician is considered adequate if
  the physician:
               (1)  periodically reviews the order; and
               (2)  is available through direct telecommunication as
  needed for consultation, assistance, and direction.
         (e)  An order issued under this section must contain:
               (1)  the name and signature of the prescribing
  physician;
               (2)  the name of the school district or open-enrollment
  charter school to which the order is issued;
               (3)  the quantity of epinephrine auto-injectors to be
  obtained and maintained under the order; and
               (4)  the date of issue.
         (f)  A pharmacist may dispense an epinephrine auto-injector
  to a school district or open-enrollment charter school without
  requiring the name or any other identifying information relating to
  the user.
         Sec. 38.212.  GIFTS, GRANTS, AND DONATIONS. A school
  district or open-enrollment charter school may accept gifts,
  grants, donations, and federal and local funds to implement this
  subchapter.
         Sec. 38.213.  RULES. Except as otherwise provided by this
  subchapter, the commissioner of education and the commissioner of
  state health services shall jointly adopt rules necessary to
  implement this subchapter.
         Sec. 38.214.  IMMUNITY FROM LIABILITY. (a)  A person who in
  good faith takes, or fails to take, any of the following actions
  under this subchapter is immune from civil or criminal liability or
  disciplinary action resulting from that action or failure to act:
               (1)  issuing an order for epinephrine auto-injectors;
               (2)  supervising or delegating the administration of an
  epinephrine auto-injector;
               (3)  possessing an epinephrine auto-injector;
               (4)  prescribing an epinephrine auto-injector;
               (5)  dispensing an epinephrine auto-injector;
               (6)  administering, or assisting in administering, an
  epinephrine auto-injector;
               (7)  providing, or assisting in providing, training,
  consultation, or advice in the development, adoption, or
  implementation of policies, guidelines, rules, or plans; or
               (8)  undertaking any other act permitted or required
  under this subchapter.
         (b)  The immunity provided by Subsection (a) is in addition
  to other immunity or limitations of liability provided by law.
         (c)  Notwithstanding any other law, this subchapter does not
  create a cause of action or liability or create a standard of care,
  obligation, or duty that provides a basis for a cause of action
  against a school district or open-enrollment charter school or
  district or school personnel for the use of, or failure to use, an
  epinephrine auto-injector as provided by this subchapter.
         SECTION 2.  Section 38.0151, Education Code, is amended by
  adding Subsection (f) to read as follows:
         (f)  A school district or open-enrollment charter school
  that provides for the maintenance and administration of epinephrine
  auto-injectors under Subchapter E is not required to comply with
  this section.
         SECTION 3.  This Act applies beginning with the 2015-2016
  school year.
         SECTION 4.  This Act takes effect immediately if it receives
  a vote of two-thirds of all the members elected to each house, as
  provided by Section 39, Article III, Texas Constitution.  If this
  Act does not receive the vote necessary for immediate effect, this
  Act takes effect September 1, 2015.